O'Rourke & Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.07M Sell
8,475
-111
-1% -$25.9K 0.82% 34
2025
Q4
$1.78M Buy
8,586
+112
+1% +$22.1K 0.69% 37
2025
Q3
$1.57M Sell
8,474
-19
-0.2% -$3.25K 0.66% 38
2025
Q2
$1.3M Buy
8,493
+6
+0.1% +$922 0.61% 39
2025
Q1
$1.41M Sell
8,487
-45
-0.5% -$7.04K 0.7% 33
2024
Q4
$1.23M Sell
8,532
-269
-3% -$41.7K 0.6% 36
2024
Q3
$1.43M Sell
8,801
-115
-1% -$18.3K 0.71% 32
2024
Q2
$1.3M Sell
8,916
-342
-4% -$50.9K 0.73% 30
2024
Q1
$1.47M Buy
9,258
+59
+0.6% +$9.39K 0.85% 29
2023
Q4
$1.44M Buy
9,199
+69
+0.8% +$10.6K 0.93% 28
2023
Q3
$1.42M Buy
9,130
+170
+2% +$28.1K 1.04% 24
2023
Q2
$1.48M Buy
8,960
+301
+3% +$48.6K 1.04% 25
2023
Q1
$1.39M Sell
8,659
-194
-2% -$31.3K 1.06% 24
2022
Q4
$1.56M Buy
8,853
+356
+4% +$61.5K 1.24% 18
2022
Q3
$1.39M Buy
8,497
+197
+2% +$33.3K 1.21% 22
2022
Q2
$1.47M Sell
8,300
-430
-5% -$76.6K 1.25% 20
2022
Q1
$1.55M Buy
8,730
+339
+4% +$57.7K 1.07% 24
2021
Q4
$1.44M Buy
+8,391
New +$1.37M 0.96% 23

Other funds holding JNJ

O'Rourke & Company's JNJ Position: Q1 2026 in Review

O'Rourke & Company reduced its Johnson & Johnson (JNJ) stake by 1.3% in Q1 2026, selling an estimated $25.9K and leaving 8,475 shares worth $2.07M. The position accounts for 0.82% of the portfolio, ranked #34.

O'Rourke & Company first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • O'Rourke & Company held 8,475 shares of Johnson & Johnson worth $2.07M as of Q1 2026.
  • O'Rourke & Company sold 111 Johnson & Johnson shares in Q1 2026, an estimated $25.9K.
  • Johnson & Johnson made up 0.82% of O'Rourke & Company's portfolio in Q1 2026, its #34 holding.
  • O'Rourke & Company first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on O'Rourke & Company's 13F filing for Q1 2026, filed 14 May 2026.